Emeryville, United States
Profusa is a biotechnology company that aims to revolutionize health and wellness by making the body's chemistry easily accessible. Founded in 2009, the company is dedicated to developing real-time biosensors that offer unprecedented insights into overall health status. Their pioneering technology integrates biocompatible sensors with the body, enabling the detection and continuous transmission of actionable, medical-grade data. The Lumee Oxygen Platform™, their first clinical offering, provides reliable tissue oxygen level reports for various regions of interest, catering to applications such as peripheral artery disease, chronic wounds, and reconstructive surgery.
Profusa's innovative approach to personalized health monitoring has the potential to significantly impact the fields of biotechnology, healthcare, health and wellness, and medical devices. The last investment, a Convertible Note investment, took place on 01 March 2021. As the company continues to make strides in transforming healthcare management, its progress and development are worth keeping an eye on.
For further information, please visit profusa.com or reach out via email at [email protected].
